Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.

NCT00040157 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

60

Enrollment

INDUSTRY

Sponsor class

Stopped Safety concerns

Conditions

HIV Infections

Interventions

DRUG: ACH126-443 (Beta-L-Fd4C)

Sponsor

Alexion Pharmaceuticals, Inc.